ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

KIAA1549 promotes the development and chemoresistance of colorectal cancer by upregulating ERCC2

Ye, Feng; Xie, Yuwen; Lin, Mingdao; Liu, Yang; Fang, Yuan; Chen, Keli; Zhang, Yaowei; Ding, Yi*南方医科大学; 1; y
Molecular and Cellular Biochemistry2023-5-4DOI: 10.1007/s11010-023-04751-x
3阅读
引用收藏
分享

摘要

Colorectal cancer (CRC) is the third most commonly diagnosed cancer worldwide. Chemotherapy is the mainstay of treatment for patients with CRC in II-IV stages. Resistance to chemotherapy occurs commonly, which results in treatment failure. Therefore, the identification of novel functional biomarkers is essential for recognizing high-risk patients, predicting recurrence, and developing new therapeutic strategies. Herein, we assessed the roles of KIAA1549 in promoting tumor development and chemoresistance in colorectal cancer. As a result, we found that KIAA1549 expression is up-regulation in CRC. Public databases revealed a progressive up-regulation of KIAA1549 expression from adenomas to carcinomas. Functional characterization uncovered that KIAA1549 promotes tumor malignant phenotypes and boosts the chemoresistance of CRC cells in an ERCC2-dependent manner. Inhibition of KIAA1549 and ERCC2 effectively enhanced the sensitivity to chemotherapeutic drugs oxaliplatin and 5-fluorouracil. Our findings suggest that endogenous KIAA1549 might function as a tumor development-promoting role and trigger chemoresistance in colorectal cancer partly by upregulating DNA repair protein ERCC2. Hence, KIAA1549 could be an effective therapeutic target for CRC and inhibition of KIAA1549 combined with chemotherapy might be a potential therapeutic strategy in the future.

学科与关键词

关键词
Colorectal cancerKIAA1549DevelopmentChemotherapyChemoresistance
相关
加载中…
  • DYRK2 downregulation in colorectal cancer leads to epithelial-mesenchymal transition induction and chemoresistance
    Wu, Chunrong; Sun, Guiyin*; Wang, Fan; Chen, Jiangyan; Zhan, Fangbiao; Lian, Xiaojuan; Wang, Jie; Weng, Fanbin; Li, Bo; Tang, Weijun; Quan, Jin; Xiang, Debing*Scientific Reports, 2022, 12(1): 22496.被引 3
  • FAM98A promotes resistance to 5-fluorouracil in colorectal cancer by suppressing ferroptosis
    He, Zhanke; Yang, Junbo; Sui, Chuyang; Zhang, Penghao; Wang, Ting; Mou, Tingyu; Sun, Kai; Wang, Yanan; Xu, Zhijun; Li, Guoxin*; Deng, Haijun*; Shi, Jiaolong*; Zhuang, Baoxiong*Archives of Biochemistry and Biophysics, 2022, 722: 109216.被引 15
  • LINC02418 upregulates EPHA2 by competitively sponging miR-372-3p to promote 5-Fu/DDP chemoresistance in colorectal cancer
    Yao, Fei; Huang, Xiaoying; Xie, Zhufu; Chen, Jie; Zhang, Ling; Wang, Qiang; Long, Hui; Jiang, Jue*; Wu, Qingming*Carcinogenesis, 2022, 43(9): 895-907.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Molecular and Cellular Biochemistry
发表日期
2023-05-04
DOI
10.1007/s11010-023-04751-x
语言
ENGLISH
成果收录
SCIE

作者

  • Y

    Ye, Feng (第一作者)

    southern med univ

  • X

    Xie, Yuwen

    southern med univ

查看全部 8 位作者收起作者
  • L

    Lin, Mingdao

    1 · southern med univ

  • L

    Liu, Yang

    southern med univ

  • F

    Fang, Yuan

    southern med univ

  • C

    Chen, Keli

    southern med univ

  • Z

    Zhang, Yaowei

    southern med univ

  • D

    Ding, Yi (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417